Loading...

23andMe Holding Co.

MEUSWNASDAQ
Healthcare
Medical - Diagnostics & Research
$1.38
$-0.13(-8.61%)

Fundamental Analysis of 23andMe Holding Co. (MEUSW)

Comprehensive financial metrics and ratios analysis
EPS (TTM)
-
P/E Ratio
-
ROE
-3.99%
Net Margin
-1.48%

Key Financial Metrices

Valuation Metrics

4 metrics
Market CapTotal market value of outstanding shares
$0.00
Shares OutstandingTotal number of shares issued
-
Book Value/ShareNet worth per share
$-1.05
Revenue/ShareAnnual revenue per share
$7.43

Profitability Metrics

6 metrics
EPS (TTM)Earnings per share trailing twelve months
-
Net MarginNet income as percentage of revenue
-147.92%
Operating MarginOperating income as percentage of revenue
-140.90%
ROEReturn on shareholders' equity
-399.25%
ROAReturn on total assets
-175.67%
ROCEReturn on capital employed
-739.30%

Cash Flow Metrics

3 metrics
Free Cash Flow/ShareCash generated per share after capex
$-6.90
Cash/ShareCash and equivalents per share
$1.50
FCF YieldFree cash flow as percentage of market cap
-1323.14%

Dividend Metrics

2 metrics
Dividend/ShareAnnual dividend payment per share
-
Dividend YieldAnnual dividend as percentage of stock price
-
Financial Ratios Analysis data is not available for MEUSWFinancial Ratios Analysis details for MEUSW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Sector Benchmarking data is not available for MEUSWSector Benchmarking details for MEUSW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for 23andMe Holding Co. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of 23andMe Holding Co.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account 23andMe Holding Co.'s unique business strengths and challenges.

Key Financial Metrics for 23andMe Holding Co.

For 23andMe Holding Co., essential financial indicators include EPS -, PE -, and ROE -3.99. These key ratios reveal insights into 23andMe Holding Co.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare 23andMe Holding Co. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of 23andMe Holding Co.

Metrics like Net Margin -147.92% and ROA -175.67% shed light on how well 23andMe Holding Co. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether 23andMe Holding Co. can sustain its operations and continue growing in the future.

Valuation and Market Position of 23andMe Holding Co.

Using ratios such as P/B Ratio -0.58 and PEG Ratio -0.00, investors can assess whether 23andMe Holding Co. is appropriately valued based on its financials and growth potential. These figures, combined with 23andMe Holding Co.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for 23andMe Holding Co.

Financial health indicators, such as Debt/Equity Ratio -2.56 and Cash Flow $-6.90, provide a snapshot of 23andMe Holding Co.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like 23andMe Holding Co., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for 23andMe Holding Co.

Investing in 23andMe Holding Co. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at 23andMe Holding Co. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;